Danaher Corporation Common Stock (DHR)
Stock · NYSE · Industrials
$229.04as of 10/16/2026
Price chart
Active signals
DHR Signal Track Record
How signals performed across all stocks →What DHR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | +0.7% | 52% | September 17, 2026 |
| Bollinger Band Breakdown | 22 | +0.5% | 50% | July 21, 2026 |
| Bollinger Band Breakout | 22 | -1.2% | 45% | August 20, 2026 |
| 200-Day Moving Average TouchActive now | 19 | -1.5% | 32% | September 10, 2026 |
| Any 20-session window (baseline) | +0.5% | 53% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of…
- Sector
- Industrials
- Industry
- Industrial Machinery/Components
- Employees
- 58,000
- Website
- www.danaher.com/
Fundamentals
- 1-day range
- $226.72$232.99
- Market cap
- $140.58B
- P/E (trailing)
- 39.43
- P/E (forward)
- 24.90
- EPS (trailing)
- $5.63
- Dividend yield
- 0.49%
- Beta
- 0.79
- Avg. volume
- 4.76M
- Ex-dividend date
- September 30, 2026
- Dividend pay date
- October 30, 2026
How Danaher Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
22 analyst ratings
Danaher Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- DHRDanaher Corporation Common Stock$229.04▼ 1.06%Market cap $140.58BP/E 39.43$160.93$242.8
- DEDeere & Company Common Stock$641.86▼ 1.35%Market cap $165.97BP/E 35.92$433$721.22
- ETNEaton Corporation PLC Ordinary Shares$391.25▼ 2.79%Market cap $174.08BP/E 39.68$311.92$478
- VRTVertiv Holdings LLC Class A Common Stock$206.42▼ 3.88%Market cap $105.94BP/E 47.50$147.82$379.94
- JCIJohnson Controls International plc Ordinary Share$145.47▼ 1.46%Market cap $93.62BP/E 24.57$104.49$160.41
- CMICummins Inc. Common Stock$531.33▼ 0.26%Market cap $88.65BP/E 26.28$400.72$737.76
- ITWIllinois Tool Works Inc. Common Stock$272.28▲ 0.40%Market cap $84.79BP/E 24.21$238.82$303.16
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DHR Danaher Corporation Common Stock | $140.58B | 39.43 | $229.04 | ▼ 1.06% | $160.93$242.8 |
| DE Deere & Company Common Stock | $165.97B | 35.92 | $641.86 | ▼ 1.35% | $433$721.22 |
| ETN Eaton Corporation PLC Ordinary Shares | $174.08B | 39.68 | $391.25 | ▼ 2.79% | $311.92$478 |
| VRT Vertiv Holdings LLC Class A Common Stock | $105.94B | 47.50 | $206.42 | ▼ 3.88% | $147.82$379.94 |
| JCI Johnson Controls International plc Ordinary Share | $93.62B | 24.57 | $145.47 | ▼ 1.46% | $104.49$160.41 |
| CMI Cummins Inc. Common Stock | $88.65B | 26.28 | $531.33 | ▼ 0.26% | $400.72$737.76 |
| ITW Illinois Tool Works Inc. Common Stock | $84.79B | 24.21 | $272.28 | ▲ 0.40% | $238.82$303.16 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 10 Health Care Stocks Whale Activity In Today’s SessionBenzinga · 10/9/2026
- Did Danaher’s (DHR) New AI-Powered Autonomous Lab at Abcam Just Redefine Its Innovation Edge?Yahoo · 10/9/2026
- Danaher (DHR) Stock May Be 4% Undervalued Despite AI Lab LaunchYahoo · 10/8/2026
- Is Danaher (DHR) Undervalued As Its New AI Lab Pushes Faster Antibody Development?Yahoo · 10/8/2026
- Danaher (DHR) Launched Its First AI Powered Autonomous LaboratoryYahoo · 10/8/2026
- Top Stock Reports for AMD, Palo Alto & ConocoPhillipsYahoo · 10/7/2026
- Danaher launching AI-powered autonomous lab for drug discoveryYahoo · 10/7/2026
- Apple ordered to pay Masimo $184M in interest on patent damagesYahoo · 10/7/2026
Insider Activity
Insider Actions →- Blair Rainer · August 21, 2026 · Sale7.8K @ $219.35
- Blair Rainer · August 21, 2026 · Sale39.2K @ $218.73
- Blair Rainer · August 21, 2026 · Sale11.3K @ $217.77
- Sawyer Montgomery Julie A · August 4, 2026 · Grant245.7K
- Christopher Paul Riley · August 4, 2026 · Grant41.1K
- Christopher Bouda · August 4, 2026 · Grant12.3K
- Jose-Carlos Gutierrez-Ramos · August 4, 2026 · Grant13.5K
- Jonathan Leiken · August 4, 2026 · Grant92.1K
- Mitchell P. Rales · August 4, 2026 · Grant1.00M
- Mitchell P. Rales · August 4, 2026 · Grant500.0K
- Steven M. Rales · August 4, 2026 · Grant1.00M
- Steven M. Rales · August 4, 2026 · Grant500.0K
- Gugino Matthew E · August 4, 2026 · Grant153.6K
- Gregory M. Milosevich · August 4, 2026 · Grant15.4K
- A. Shane Sanders · July 31, 2026 · Grant211 @ $194.98
Institutional Ownership
March 31, 2026
- Total shares held
- 539.27M
- Total value held
- $96.08B
- Institutional holders
- 2143
- Unknown51.64M
- Unknown41.13M
- Unknown27.89M
- Unknown22.53M
- Unknown15.35M
- Unknown14.77M
- Unknown14.15M
- Unknown14.01M
- Unknown11.21M
- Unknown8.90M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Danaher Expands AI Integration in Scientific Research
Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.
Danaher Expands AI Integration in Scientific Research. Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.